Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Baxter International Inc.

Headquarters: Deerfield, IL, United States of America
Year Founded: 1931
Status: Public
Industry Sector: HealthTechnology
CEO: D. Brent Shafer, MD
Number Of Employees: 38,000
Enterprise Value: $26,614,600,000
PE Ratio: -27.17
Exchange/Ticker 1: NYSE:BAX
Exchange/Ticker 2: N/A
Latest Market Cap: $17,676,644,352

BioCentury | Mar 7, 2025
Management Tracks

Abbas Kazimi succeeds Jeb Keiper as CEO of Nimbus

Plus: Jon Garay Alonso named CFO of Almirall, and updates from Certara and Immunai
BioCentury | Apr 16, 2024
Management Tracks

Viatris hires Corinne Le Goff as commercial head

Plus: Exact, Obsidian name new CFOs and updates from Applied, Faron, Athira and more
BioCentury | May 9, 2023
Deals

May 8 Quick Takes: EQRx reset brings end of China deals, layoffs 

Plus: Legend’s $350M raise helps May follow-ons top April tally; ADC deals by Eisai-BlissBio, FibroGen-Fortis; and more
BioCentury | Mar 28, 2023
Finance

Sofinnova Partners’ digital strategy to address ‘sea change’ in data, computation and biology

Pair of partners to lead firm’s sixth official strategy backing start-ups with healthcare-enabling tech, analytics and digital therapeutics
BioCentury | Jan 31, 2023
Management Tracks

Baxter’s Accogli named CEO of Chiesi

Plus: J&J CMO Waldstreicher retiring, and updates from the Broad Institute, Ring, Hansa, Vaccitech and Beyond Air
BioCentury | Mar 9, 2022
Management Tracks

Oxford spinout MiroBio adds Keswani as CMO, promotes Murray to CSO

Plus updates from Centessa, Teon, AnchorDx, Pillar and more
BioCentury | Jan 21, 2022
Emerging Company Profile

ImmPACT: uniting CAR T platforms for ‘logic-gate’ therapies

Los Angeles-area biotech has $111M series B, early clinical data in hand as it advances bispecific CAR T
BioCentury | Oct 6, 2021
Management Tracks

Weinstein becomes CFO at Caris Life Sciences

Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
BioCentury | Sep 9, 2021
Management Tracks

Hayes joins Fulcrum as chief commercial officer

Plus: ImmunityBio, Finch, Rhythm, Infinity, Locanabio and more
BioCentury | Feb 5, 2021
Product Development

Big shoes: Davis needs to fill Merck’s post-Keytruda pipeline as Frazier shifts to executive chair

Focus will be on modest, early-stage deals as the pharma seeks next blockbuster
Items per page:
1 - 10 of 655
Help Center
Username
Request a Demo
Request Training
Ask a Question